Encyclopedia of Signaling Molecules

2018 Edition
| Editors: Sangdun Choi

P-Rex1

  • Kirsti Hornigold
  • Elpida Tsonou
  • Chiara Pantarelli
  • Heidi C. E. Welch
Reference work entry
DOI: https://doi.org/10.1007/978-3-319-67199-4_101726

Synonyms

Historical Background

P-Rex1 (PIP3-dependent Rac exchanger 1, PREX1) is a Dbl-type guanine-nucleotide exchange factor (GEF) that activates Rac-like small G proteins (small GTPases). P-Rex1 was discovered in 2002, during a search for targets of the lipid second messenger phosphatidyl inositol (3,4,5)-trisphosphate (PIP3) which is generated by phosphoinositide 3-kinase (PI3K) (Welch et al. 2002). At the time, it was known that PI3K can activate Rac and that this activation must occur indirectly, through unknown mediators. P-Rex1 was purified on the basis of its ability to activate recombinant Rac1 in the presence of PIP3 (Welch et al. 2002). The Gβγ subunits of heterotrimeric G proteins, which are released upon the activation of G...

This is a preview of subscription content, log in to check access.

References

  1. Barrio-Real L, Benedetti LG, Engel N, Tu Y, Cho S, Sukumar S, et al. Subtype-specific overexpression of the Rac-GEF P-REX1 in breast cancer is associated with promoter hypomethylation. Breast Cancer Res. 2014;16:441.PubMedPubMedCentralCrossRefGoogle Scholar
  2. Barrows D, He JZ, Parsons R. PREX1 protein function is negatively regulated downstream of receptor tyrosine kinase activation by p21-activated Kinases (PAKs). J Biol Chem. 2016;291:20042–54.PubMedPubMedCentralCrossRefGoogle Scholar
  3. Cash JN, Davis EM, Tesmer JJ. Structural and biochemical characterization of the catalytic core of the metastatic factor P-Rex1 and its regulation by PtdIns(3,4,5)P3. Structure. 2016;24:730–40.PubMedPubMedCentralCrossRefGoogle Scholar
  4. Chavez-Vargas L, Adame-Garcia SR, Cervantes-Villagrana RD, Castillo-Kauil A, Bruystens JG, Fukuhara S, et al. Protein Kinase A (PKA) Type I interacts with P-Rex1, a Rac Guanine Nucleotide Exchange Factor: effect on PKA localization and P-Rex1 signaling. J Biol Chem. 2016;291:6182–99.PubMedPubMedCentralCrossRefGoogle Scholar
  5. Dillon LM, Bean JR, Yang W, Shee K, Symonds LK, Balko JM, et al. P-REX1 creates a positive feedback loop to activate growth factor receptor, PI3K/AKT and MEK/ERK signaling in breast cancer. Oncogene. 2015;34:3968–76.CrossRefPubMedGoogle Scholar
  6. Goel HL, Pursell B, Shultz LD, Greiner DL, Brekken RA, Vander Kooi CW, et al. P-Rex1 promotes resistance to VEGF/VEGFR-targeted therapy in prostate cancer. Cell Rep. 2016;14:2193–208.PubMedPubMedCentralCrossRefGoogle Scholar
  7. Li J, Chai A, Wang L, Ma Y, Wu Z, Yu H, et al. Synaptic P-Rex1 signaling regulates hippocampal long-term depression and autism-like social behavior. Proc Natl Acad Sci U S A. 2015;112:E6964–72.PubMedPubMedCentralCrossRefGoogle Scholar
  8. Liang Q, Cheng N, Zhang G, Liang Y, Qian F, Wu D, et al. Identification of P-Rex1 as an anti-inflammatory and anti-fibrogenic target for pulmonary fibrosis. Sci Rep. 2016;6:25785.PubMedPubMedCentralCrossRefGoogle Scholar
  9. Liu HJ, Ooms LM, Srijakotre N, Man J, Vieusseux J, Waters JE, et al. PtdIns(3,4,5)P3-dependent Rac Exchanger 1 (PREX1) Rac-Guanine Nucleotide Exchange Factor (GEF) activity promotes breast cancer cell proliferation and tumor growth via activation of Extracellular Signal-Regulated Kinase 1/2 (ERK1/2) Signaling. J Biol Chem. 2016;291:17258–70.PubMedPubMedCentralCrossRefGoogle Scholar
  10. Lopez-Haber C, Barrio-Real L, Casado-Medrano V, Kazanietz MG. Heregulin/ErbB3 signaling enhances CXCR4-driven Rac1 activation and breast cancer cell motility via Hypoxia-Inducible Factor 1alpha. Mol Cell Biol. 2016;36:2011–26.PubMedPubMedCentralCrossRefGoogle Scholar
  11. Lucato CM, Halls ML, Ooms LM, Liu HJ, Mitchell CA, Whisstock JC, et al. The Phosphatidylinositol (3,4,5)-trisphosphate-dependent Rac Exchanger 1:Ras-related C3 Botulinum Toxin Substrate 1 (P-Rex1:Rac1) complex reveals the basis of Rac1 activation in breast cancer cells. J Biol Chem. 2015;290:20827–40.PubMedPubMedCentralCrossRefGoogle Scholar
  12. Marei H, Carpy A, Woroniuk A, Vennin C, White G, Timpson P, et al. Differential Rac1 signalling by guanine nucleotide exchange factors implicates FLII in regulating Rac1-driven cell migration. Nat Commun. 2016a;7:10664.PubMedPubMedCentralCrossRefGoogle Scholar
  13. Marei H, Carpy A, Macek B, Malliri A. Proteomic analysis of Rac1 signaling regulation by guanine nucleotide exchange factors. Cell Cycle. 2016b;15:1961–74.PubMedPubMedCentralCrossRefGoogle Scholar
  14. Mitchell JS, Li N, Weinhold N, Forsti A, Ali M, van Duin M, et al. Genome-wide association study identifies multiple susceptibility loci for multiple myeloma. Nat Commun. 2016;7:12050.PubMedPubMedCentralCrossRefGoogle Scholar
  15. Pan D, Amison RT, Riffo-Vasquez Y, Spina D, Cleary SJ, Wakelam MJ, et al. P-Rex and Vav Rac-GEFs in platelets control leukocyte recruitment to sites of inflammation. Blood. 2015;125:1146–58.PubMedPubMedCentralCrossRefGoogle Scholar
  16. Pan D, Barber MA, Hornigold K, Baker MJ, Toth JM, Oxley D, et al. Norbin stimulates the catalytic activity and plasma membrane localization of the Guanine-Nucleotide Exchange Factor P-Rex1. J Biol Chem. 2016;291:6359–75.PubMedPubMedCentralCrossRefGoogle Scholar
  17. Ryan MB, Finn AJ, Pedone KH, Thomas NE, Der CJ, Cox AD. ERK/MAPK signaling drives overexpression of the Rac-GEF, PREX1, in BRAF- and NRAS-mutant melanoma. Mol Cancer Res. 2016;14:1009–18.PubMedPubMedCentralCrossRefGoogle Scholar
  18. Welch HC. Regulation and function of P-Rex family Rac-GEFs. Small GTPases. 2015;6:1–11.CrossRefGoogle Scholar
  19. Welch HC, Coadwell WJ, Ellson CD, Ferguson GJ, Andrews SR, Erdjument-Bromage H, et al. P-Rex1, a PtdIns(3,4,5)P3- and Gβγ-regulated guanine-nucleotide exchange factor for Rac. Cell. 2002;108:809–21.PubMedPubMedCentralCrossRefGoogle Scholar
  20. Xue R, Lynes MD, Dreyfuss JM, Shamsi F, Schulz TJ, Zhang H, et al. Clonal analyses and gene profiling identify genetic biomarkers of the thermogenic potential of human brown and white preadipocytes. Nat Med. 2015;21:760–8.PubMedPubMedCentralCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  • Kirsti Hornigold
    • 1
  • Elpida Tsonou
    • 1
  • Chiara Pantarelli
    • 1
  • Heidi C. E. Welch
    • 1
  1. 1.Signalling ProgrammeBabraham InstituteCambridgeUK